B

BioMarin Nederland B.V.

11 employees

Prosensa provides RNA-based therapeutics for the treatment of genetic disorders, infections and cancers.

Investor insights

Sectors invested in

Therapeutics1

Genetics1

Biotechnology1

Medical1

Health Care1

Funding rounds participated in

$30M sweet spot round size

Most of their 1 investments are in rounds between $30M and $30M

Basic info

Industry

biotechnology

Sectors

Biotechnology

Health Care

Therapeutics

Genetics

Medical

Date founded

2002

Investments made

B

BioMarin Nederland B.V. raised $30M on January 25, 2012

Investors: Idinvest Partners, Abingworth, EQT Life Sciences and BioMarin Nederland B.V.

Funding rounds raised

Total raised

$30M

from 10 investors over 10 rounds

B

BioMarin Nederland B.V. raised $200K on July 2, 2014

Investors: Parent Project Muscular Dystrophy

B

BioMarin Nederland B.V. raised $30M on January 25, 2012

Investors: BioMarin Nederland B.V., Idinvest Partners, Abingworth and EQT Life Sciences

B

BioMarin Nederland B.V. raised $25M on December 17, 2008

Investors: Gimv and Idinvest Partners

B

BioMarin Nederland B.V. raised undisclosed on December 1, 2008

Investors: Idinvest Partners

B

BioMarin Nederland B.V. raised $18M on February 1, 2007

Investors: EQT Life Sciences and Abingworth